Co-delivery of a STING agonist and indoleamine 2,3-dioxygenase 1 blockade activates type I dendritic cells in cancer
Fields of Study & Subjects
interferon and immune responses
Nanoplatforms for cancer theranostics
Tryptophan and brain disorders
Publication details
- Journal / source
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Volume
- 392
- Pages
- 114731–114731
- Publication date
- 15 February 2026
- Language
- EN